SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
- Conditions
- COVID19
- Registration Number
- NCT04497610
- Lead Sponsor
- Instituto Costarricense de Investigaciones Clínicas ICIC
- Brief Summary
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.
- Detailed Description
BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.
A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel.
The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Older than 7 years odf age Able to provide informed consent Able to take the breath test
Younger than 7 years of age Unable to provide informed consent Unable to take the breath test
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of disease 1 minute Established diagnosis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Instituto Costarricense de Investigaciones Clínicas
🇨🇷San José, Costa Rica
Instituto Costarricense de Investigaciones Clínicas🇨🇷San José, Costa Rica